» Articles » PMID: 26696789

SBRT: A Viable Option for Treating Adrenal Gland Metastases

Overview
Specialty Oncology
Date 2015 Dec 24
PMID 26696789
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The management strategy of adrenal metastases depends on different clinical situations. Adrenal metastasectomy in selected patients with isolated adrenal metastases is considered the treatment of choice, showing prolonged survival compared to chemotherapy alone. More recently, Stereotactic Body Radiation Therapy (SBRT) has emerged as an alternative local ablative treatment modality although limited data are available on the use of SBRT in treating adrenal gland metastases. Preliminary results are, however, encouraging, especially in selected patients with oligometastatic disease. We herewith review and discuss the potential role of SBRT as a local ablative treatment modality for adrenal metastases.

Citing Articles

Lower fluorodeoxyglucose positron emission tomography maximum standardized uptake value may show a better response to stereotactic body radiotherapy of adrenals in oligometastatic disease.

Zhelev K, Mihaylova-Hristov M, Conev N, Cholakova M, Korabova B, Petrov I Contemp Oncol (Pozn). 2024; 27(4):263-268.

PMID: 38405207 PMC: 10883199. DOI: 10.5114/wo.2023.135288.


Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.

Xu B, Zhao X, Chen D, Zhao W, Wang X, Ding C BMC Cancer. 2023; 23(1):73.

PMID: 36681809 PMC: 9862519. DOI: 10.1186/s12885-023-10519-9.


Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results.

Michalet M, Bettaieb O, Khalfi S, Ghorbel A, Valdenaire S, Debuire P J Clin Med. 2023; 12(1).

PMID: 36615093 PMC: 9821305. DOI: 10.3390/jcm12010291.


Stereotactic radiotherapy for adrenal oligometastases.

Borghesi S, Casamassima F, Aristei C, Grandinetti A, Di Franco R Rep Pract Oncol Radiother. 2022; 27(1):52-56.

PMID: 35402020 PMC: 8989453. DOI: 10.5603/RPOR.a2021.0104.


Management of an Unusual Metastasis of Cervical Cancer in the Adrenal Bed With Stereotactic Ablative Body Radiation Therapy.

Puente-Vallejo R, Ochoa P, Nunez C, De Los Reyes L Cureus. 2022; 14(2):e22178.

PMID: 35308681 PMC: 8923247. DOI: 10.7759/cureus.22178.


References
1.
Henry J, Sebag F, Iacobone M, Mirallie E . Results of laparoscopic adrenalectomy for large and potentially malignant tumors. World J Surg. 2002; 26(8):1043-7. DOI: 10.1007/s00268-002-6666-0. View

2.
Soffen E, Solin L, Rubenstein J, Hanks G . Palliative radiotherapy for symptomatic adrenal metastases. Cancer. 1990; 65(6):1318-20. DOI: 10.1002/1097-0142(19900315)65:6<1318::aid-cncr2820650611>3.0.co;2-h. View

3.
Rubio C, Morera R, Hernando O, Leroy T, Lartigau S . Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumors. Rep Pract Oncol Radiother. 2014; 18(6):387-96. PMC: 3863325. DOI: 10.1016/j.rpor.2013.09.009. View

4.
Katoh N, Onimaru R, Sakuhara Y, Abo D, Shimizu S, Taguchi H . Real-time tumor-tracking radiotherapy for adrenal tumors. Radiother Oncol. 2008; 87(3):418-24. DOI: 10.1016/j.radonc.2008.03.013. View

5.
Walz M, Peitgen K, Diesing D, Petersenn S, Janssen O, Philipp T . Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias. World J Surg. 2004; 28(12):1323-9. DOI: 10.1007/s00268-004-7667-y. View